Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Cancer is the second most common cause of mortality and morbidity in kidney transplant
recipients after cardiovascular disease. Kidney transplant recipients have at least a twofold …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Malignancy has become one of the three major causes of death after transplantation in the
past decade and is thus increasingly important in all organ transplant programs. Death from …

Tuberculosis (TB) is a possible complication of solid organ and hematopoietic stem cell
transplantation. The identification of candidates for preventive chemotherapy is an effective …

Background The effects of obesity on outcomes reported after kidney transplantation have
been controversial. The purpose of this systematic review and meta-analysis was to …

In kidney transplant recipients, cancer is one of the leading causes of death with a
functioning graft beyond the first year of kidney transplantation, and malignancies account …

The end-stage renal disease population is aging. Nearly half of all new patients are older
than 65 years and one third are older than 70 years. Assessing the possibility of …

The link between chronic kidney disease (CKD) and tuberculosis (TB) has been known for
more than 40 years, but the interaction between these 2 diseases is still poorly understood …

Outcomes of kidney transplantation, in terms of graft and patient survival, have improved
over the past few decades, partly as a result of the introduction of new immunosuppressive …